- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Hologic completes FluoroScan purchase
Bone densitometry firm Hologic last month finalized its purchaseof mini C-arm developer FluoroScan Imaging Systems of Northbrook,IL (SCAN 7/31/96). Hologic, of Waltham, MA, completed the acquisitionthrough a stock swap, in which each share of FluoroScan
Bone densitometry firm Hologic last month finalized its purchase
of mini C-arm developer FluoroScan Imaging Systems of Northbrook,
IL (SCAN 7/31/96). Hologic, of Waltham, MA, completed the acquisition
through a stock swap, in which each share of FluoroScan stock
was exchanged for 0.31069 shares of Hologic stock. The acquisition
is the first step in Hologic's strategy to diversify into new
markets, according to chairman and CEO David Ellenbogen.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
